Watch the full talk on demand now ➡️ pvrinstitute.org/learning-hub...

#PVRI2025 #CTEPH #MachineLearning #PulmonaryHypertension

Missed Pietro Nardelli's talk at #PVRI2025? Now's your time to catch up!🎦

🎥 Missed Dunbar Ivy's presentation on 'classification & diagnosis of paediatric PH' at #PVRI2025? Watch the full recording now → pvrinstitute.org/learning-hub... #PVRI2025 #PaediatricPH #PulmonaryHypertension

Missed Khodr Tello's talk on cardiopulmonary exercise testing in the diagnosis & phenotyping of PH patients at #PVRI2025? Now’s your chance to catch up! Watch the full talk on demand now➡️ pvrinstitute.org/learning-hub... #PulmonaryHypertension #Cardiopulmonary #ExerciseTesting

Missed Ravikumar Sitapara's talk on the combination of seralutinib & sotatercept in preclinical models at #PVRI2025? Now’s your chance to catch up! 🎦 Watch the full talk on demand now pvrinstitute.org/learning-hub... #PAH #seralutinib #sotatercept

A beautiful few days in Rio catching up with friends and colleagues from around the world in #pulmonaryvascular disease. It was amazing to see my prior mentors Brian Graham and Rubin Tuder receive the PVRI Achievement Award and Lifetime Achievement Award! Looking forward to next year. #pvri2025

Interesting talk about 'Elevated vascular hyaluronan as a therapeutic target in PH associated with lung fibrosis' by Harry Karmouty Quintana #PVRI2025

Continuing the morning session at #PVRI2025 with more discussion on Imaging insights on the vasculature in chronic lung disease.

Exciting presentations and questions about vascular heterogeneity in chronic lung disease. Lots of discussion on clustering and endophenotyping PH associated with COPD. #PVRI2025

Had and excellent pre-conference meeting for the PVRI imaging task force. Excellent discussion on access to multi-center imaging, quantification of vascular size and remodeling, CMR 4D flow and use of AI methods in imaging associated with PH. #PVRI2025

Excited for the first day of #PVRI2025 Diving into the heterogeneity of pulmonary vascular disease.